NASDAQ : ANIK
Anika Therapeutics, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 20.95 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 280.37M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Anika Therapeutics, Inc. (ANIK) reported revenue of 120.65M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 120.65M | 112.82M | 119.91M | 120.79M | 113.83M | 147.79M |
| Cost of Revenue | 45.65M | 49.01M | 43.30M | 38.26M | 40.61M | 58.39M |
| Gross Profit | 75.00M | 63.81M | 76.60M | 82.53M | 73.22M | 89.41M |
| Selling, General & Admin | 50.15M | 49.09M | 55.55M | 59.92M | 51.23M | 74.10M |
| Research & Development | 27.45M | 25.77M | 25.54M | 21.76M | 18.32M | 27.33M |
| Operating Expenses | 77.60M | 74.86M | 81.10M | 81.69M | 69.55M | 101.42M |
| Operating Income | -2.59M | -11.05M | -4.50M | 844.00K | 3.67M | -12.02M |
| Interest Expense | -188.00K | |||||
| Interest & Investment Income | 2.21M | 1.74M | 2.34M | 2.31M | 654.00K | |
| EBT Excluding Unusual Items | -385.00K | -9.31M | -2.16M | 3.16M | 4.32M | -12.20M |
| Merger & Restructuring Charges | -2.36M | -606.00K | -6.46M | |||
| Other Unusual Items | -169.00K | 21.09M | ||||
| Pretax Income | -2.91M | -9.31M | -2.76M | 3.16M | 4.32M | 2.43M |
| Income Tax Expense | 208.00K | 672.00K | 6.06M | 6.59M | 2.12M | -1.71M |
| Earnings From Continuing Operations | -3.12M | -9.98M | -8.83M | -3.44M | 2.20M | 4.13M |
| Earnings From Discontinued Operations | -663.00K | -901.00K | -47.56M | -79.23M | -17.06M | |
| Net Income | -3.78M | -10.88M | -56.38M | -82.67M | -14.86M | 4.13M |
| Net Income to Common | -3.78M | -10.88M | -56.38M | -82.67M | -14.86M | 4.13M |
| Shares Outstanding (Basic) | 13.89M | 14.34M | 14.72M | 14.66M | 14.56M | 14.40M |
| Shares Outstanding (Diluted) | 13.89M | 14.34M | 14.72M | 14.66M | 14.56M | 14.63M |
| EPS (Basic) | -0.27 | -0.76 | -3.83 | -5.64 | -1.02 | 0.29 |
| EPS (Diluted) | -0.28 | -0.76 | -3.83 | -5.64 | -1.02 | 0.28 |
| Free Cash Flow | 562.00K | 4.36M | -2.33M | -7.21M | -3.08M | 3.25M |
| Free Cash Flow Per Share | 0.04 | 0.30 | -0.16 | -0.49 | -0.21 | 0.22 |
| Gross Margin | 62.17% | 56.56% | 63.89% | 68.33% | 64.33% | 60.49% |
| Operating Margin | -2.15% | -9.79% | -3.75% | 0.70% | 3.22% | -8.13% |
| Profit Margin | -3.14% | -9.64% | -47.02% | -68.44% | -13.05% | 2.80% |
| Free Cash Flow Margin | 0.47% | 3.87% | -1.94% | -5.97% | -2.70% | 2.20% |
| EBITDA | 3.04M | -5.47M | 1.19M | 6.35M | 9.16M | 2.30M |
| EBITDA Margin | 2.52% | -4.85% | 1.00% | 5.26% | 8.04% | 1.56% |
| D&A For EBITDA | 5.63M | 5.58M | 5.69M | 5.51M | 5.49M | 14.32M |
| EBIT | -2.59M | -11.05M | -4.50M | 844.00K | 3.67M | -12.02M |
| EBIT Margin | -2.15% | -9.79% | -3.75% | 0.70% | 3.22% | -8.13% |
| Effective Tax Rate | 208.97% | 49.12% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 38.41M | 57.48M | 55.63M | 68.74M | 86.33M | 94.39M |
| Cash & Short-Term Investments | 38.41M | 57.48M | 55.63M | 68.74M | 86.33M | 94.39M |
| Receivables | 29.06M | 23.69M | 23.59M | 26.36M | 34.63M | 29.84M |
| Inventory | 28.57M | 18.79M | 23.81M | 24.43M | 39.77M | 36.01M |
| Prepaid Expenses | 3.15M | 3.40M | 5.49M | 7.48M | 8.83M | 8.29M |
| Other Current Assets | 5.13M | 36.30M | ||||
| Total Current Assets | 99.19M | 103.36M | 113.65M | 163.31M | 169.55M | 168.53M |
| Property, Plant & Equipment | 65.05M | 66.26M | 64.68M | 65.00M | 78.97M | 68.56M |
| Goodwill | 7.83M | 8.05M | 7.12M | 7.57M | 7.34M | 7.78M |
| Other Intangible Assets | 1.65M | 1.65M | 2.49M | 2.58M | 74.60M | 82.38M |
| Long-Term Deferred Tax Assets | 1.02M | 1.27M | 1.18M | 1.49M | 1.45M | |
| Other Long-Term Assets | 3.02M | 4.03M | 7.68M | 30.69M | 17.22M | 20.29M |
| Total Assets | 183.47M | 190.27M | 202.74M | 270.63M | 349.13M | 347.54M |
| Accounts Payable | 6.24M | 6.04M | 5.62M | 6.19M | 9.07M | 7.63M |
| Accrued Expenses | 13.53M | 13.81M | 11.59M | 11.00M | 15.96M | 16.13M |
| Current Portion of Leases | 1.94M | 2.05M | 1.92M | 1.83M | 2.07M | 1.71M |
| Current Income Taxes Payable | 63.00K | 1.24M | 810.00K | |||
| Current Unearned Revenue | 122.00K | |||||
| Other Current Liabilities | 326.00K | 4.12M | 10.80M | 4.32M | ||
| Total Current Liabilities | 22.15M | 21.91M | 23.31M | 31.06M | 27.91M | 29.80M |
| Long-Term Leases | 23.32M | 24.20M | 24.01M | 25.91M | 28.82M | 19.24M |
| Long-Term Deferred Tax Liabilities | 6.44M | 10.16M | ||||
| Other Long-Term Liabilities | 730.00K | 701.00K | 1.43M | 1.39M | 398.00K | 1.26M |
| Total Liabilities | 46.19M | 46.80M | 48.75M | 58.37M | 63.56M | 60.45M |
| Common Stock | 134.00K | 139.00K | 144.00K | 147.00K | 146.00K | 144.00K |
| Additional Paid-In Capital | 83.44M | 87.50M | 88.96M | 90.01M | 81.14M | 67.08M |
| Retained Earnings | 59.04M | 60.79M | 71.67M | 128.05M | 210.72M | 225.58M |
| Comprehensive Income & Other | -5.33M | -4.96M | -6.78M | -5.94M | -6.44M | -5.72M |
| Shareholders' Equity | 137.28M | 143.47M | 153.99M | 212.26M | 285.56M | 287.08M |
| Total Liabilities & Equity | 183.47M | 190.27M | 202.74M | 270.63M | 349.13M | 347.54M |
| Total Debt | 25.25M | 26.25M | 25.93M | 27.74M | 30.89M | 20.95M |
| Net Cash (Debt) | 13.16M | 31.23M | 29.70M | 41.00M | 55.44M | 73.43M |
| Net Cash Per Share | 0.95 | 2.18 | 2.02 | 2.80 | 3.81 | 5.02 |
| Filing Date Shares Outstanding | 13.38M | 13.40M | 14.18M | 14.66M | 14.63M | 14.47M |
| Total Common Shares Outstanding | 13.38M | 13.89M | 14.42M | 14.66M | 14.62M | 14.44M |
| Working Capital | 77.04M | 81.45M | 90.35M | 132.25M | 141.63M | 138.73M |
| Book Value Per Share | 10.26 | 10.33 | 10.68 | 14.48 | 19.53 | 19.88 |
| Tangible Book Value | 127.81M | 133.76M | 144.37M | 202.12M | 203.62M | 196.92M |
| Tangible Book Value Per Share | 9.55 | 9.63 | 10.01 | 13.79 | 13.92 | 13.64 |
| Machinery | 55.17M | 51.20M | 42.90M | 44.39M | 54.52M | 51.19M |
| Construction In Progress | 2.13M | 3.73M | 6.04M | 2.39M | 5.02M | 1.38M |
| Leasehold Improvements | 37.02M | 36.82M | 36.34M | 34.65M | 34.92M | 34.61M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -3.78M | -10.88M | -56.38M | -82.67M | -14.86M | 4.13M |
| Depreciation & Amortization | 5.63M | 5.58M | 5.69M | 5.51M | 5.49M | 14.32M |
| Loss (Gain) From Sale of Assets | 255.00K | -166.00K | 2.86M | 1.92M | 993.00K | |
| Asset Writedown & Restructuring Costs | 2.46M | 62.19M | 600.00K | |||
| Stock-Based Compensation | 13.15M | 10.08M | 13.13M | 15.24M | 14.31M | 11.09M |
| Provision & Write-off of Bad Debts | 35.00K | 265.00K | 1.19M | 190.00K | 378.00K | 64.00K |
| Other Operating Activities | 5.79M | 6.98M | 47.12M | -755.00K | 1.91M | -8.08M |
| Change in Accounts Receivable | -5.66M | 408.00K | 3.37M | -1.30M | -5.63M | -6.22M |
| Change in Inventory | -13.64M | 30.00K | -9.42M | -11.40M | -6.87M | -6.62M |
| Change in Accounts Payable | 1.28M | 42.00K | -2.51M | -11.00K | 1.97M | -1.10M |
| Change in Income Taxes | 1.44M | -134.00K | 665.00K | 530.00K | 1.44M | -1.31M |
| Change in Other Net Operating Assets | 1.49M | -1.17M | -5.19M | 59.00K | -2.72M | 528.00K |
| Operating Cash Flow | 5.98M | 11.19M | 5.40M | -1.79M | 4.41M | 8.40M |
| Capital Expenditures | -5.42M | -6.83M | -7.73M | -5.43M | -7.49M | -5.14M |
| Cash Acquisitions | -476.00K | |||||
| Divestitures | 4.50M | |||||
| Sale (Purchase) of Intangibles | 600.00K | -600.00K | ||||
| Investment in Securities | 2.50M | |||||
| Other Investing Activities | 1.36M | 1.33M | ||||
| Investing Cash Flow | -4.05M | -401.00K | -8.33M | -5.43M | -7.49M | -3.12M |
| Long-Term Debt Repaid | -284.00K | -201.00K | ||||
| Net Debt Issued (Repaid) | -284.00K | -201.00K | ||||
| Issuance of Common Stock | 449.00K | 500.00K | 784.00K | 828.00K | 681.00K | 1.13M |
| Repurchase of Common Stock | -16.79M | -11.05M | -13.51M | -7.15M | -934.00K | -486.00K |
| Other Financing Activities | -4.32M | -7.22M | ||||
| Financing Cash Flow | -16.34M | -10.55M | -12.73M | -6.32M | -4.85M | -6.78M |
| Foreign Exchange Rate Adjustments | -339.00K | 86.00K | -48.00K | 79.00K | -130.00K | 69.00K |
| Net Cash Flow | -14.76M | 322.00K | -15.71M | -13.46M | -8.06M | -1.43M |
| Free Cash Flow | 562.00K | 4.36M | -2.33M | -7.21M | -3.08M | 3.25M |
| Free Cash Flow Margin | 0.47% | 3.87% | -1.94% | -5.97% | -2.70% | 2.20% |
| Free Cash Flow Per Share | 0.04 | 0.30 | -0.16 | -0.49 | -0.21 | 0.22 |
| Levered Free Cash Flow | 3.06M | 13.28M | 35.40M | 6.19M | 2.59M | 10.35M |
| Unlevered Free Cash Flow | 3.06M | 13.28M | 35.40M | 6.19M | 2.59M | 10.47M |
| Cash Income Tax Paid | 1.08M | 1.08M | 3.99M | 3.12M | 106.00K | 1.23M |
| Change in Working Capital | -15.10M | -823.00K | -13.09M | -12.12M | -11.82M | -14.72M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 280.37M | 138.59M | 241.07M | 331.76M | 432.45M | 517.27M |
| Enterprise Value | 267.21M | 105.10M | 206.23M | 290.42M | 375.77M | 447.47M |
| Last Close Price | 20.95 | 9.61 | 16.46 | 22.66 | 29.60 | 35.83 |
| PE Ratio | 125.13 | |||||
| Forward PE | 23.54 | 53.39 | 39.19 | 72.08 | 72.08 | 112.55 |
| PS Ratio | 2.32 | 1.23 | 2.01 | 2.75 | 3.80 | 3.50 |
| PB Ratio | 2.04 | 0.97 | 1.56 | 1.56 | 1.51 | 1.80 |
| P/TBV Ratio | 2.19 | 1.04 | 1.67 | 1.64 | 2.12 | 2.63 |
| P/FCF Ratio | 498.88 | 31.77 | 158.96 | |||
| P/OCF Ratio | 46.91 | 12.39 | 44.62 | 98.08 | 61.60 | |
| PEG Ratio | 2.35 | 11.40 | 1.96 | 3.60 | 3.60 | 161.40 |
| EV/Sales Ratio | 2.21 | 0.93 | 1.72 | 2.40 | 3.30 | 3.03 |
| EV/EBITDA Ratio | 87.90 | 172.87 | 45.73 | 41.04 | 194.38 | |
| EV/EBIT Ratio | 344.10 | 102.39 | ||||
| EV/FCF Ratio | 475.46 | 24.10 | 137.51 | |||
| Debt / Equity Ratio | 0.18 | 0.18 | 0.17 | 0.13 | 0.11 | 0.07 |
| Debt / EBITDA Ratio | 8.31 | 5.25 | 2.75 | 2.49 | 4.12 | |
| Debt / FCF Ratio | 44.93 | 6.02 | 6.44 | |||
| Net Debt / Equity Ratio | -0.10 | -0.22 | -0.19 | -0.19 | -0.19 | -0.26 |
| Net Debt / EBITDA Ratio | -4.33 | 5.71 | -24.89 | -6.46 | -6.05 | -31.90 |
| Net Debt / FCF Ratio | -23.42 | -7.16 | 12.74 | 5.68 | 18.02 | -22.57 |
| Asset Turnover | 0.65 | 0.57 | 0.51 | 0.39 | 0.33 | 0.41 |
| Inventory Turnover | 2.01 | 2.30 | 1.79 | 1.19 | 1.07 | 1.42 |
| Quick Ratio | 3.05 | 3.71 | 3.40 | 3.06 | 4.33 | 4.17 |
| Current Ratio | 4.48 | 4.72 | 4.88 | 5.26 | 6.07 | 5.66 |
| Return on Equity (ROE) | -2.19% | -6.71% | -4.82% | -1.38% | 0.77% | 1.48% |
| Return on Assets (ROA) | -0.87% | -3.52% | -1.19% | 0.17% | 0.66% | -2.11% |
| Return on Invested Capital (ROIC) | -2.14% | -9.35% | -3.04% | -0.46% | 0.84% | -5.86% |
| Return on Capital Employed (ROCE) | -1.60% | -6.60% | -2.50% | 0.40% | 1.10% | -3.80% |
| Earnings Yield | -1.32% | -7.85% | -23.39% | -24.92% | -3.44% | 0.80% |
| FCF Yield | 0.20% | 3.15% | -0.97% | -2.17% | -0.71% | 0.63% |
| Buyback Yield / Dilution | 4.23% | 2.60% | -0.44% | -0.65% | 0.50% | -2.90% |